Last Updated: May 11, 2026

Profile for Australia Patent: 2022328272


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2022328272

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,285,432 Aug 11, 2042 Sun Pharm Inds Inc LEQSELVI deuruxolitinib phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Australian Patent AU2022328272: Scope, Claims, and Patent Landscape Analysis

Last updated: February 21, 2026

Overview

Patent AU2022328272 covers a pharmaceutical invention, granted in Australia in 2023. It appears to primarily protect a specific formulation or method related to a therapeutic compound. Analyzing its scope and claims reveals the breadth of protection and the patent landscape context.

Scope and Claims Analysis

Core Claims

The patent contains a set of independent claims that define the invention's core protection. These claims typically specify:

  • The chemical structure or composition of the drug.
  • The concentration ranges of active ingredients.
  • Specific formulation methods or delivery mechanisms.
  • Medical indications or methods of use.

Claim Hierarchy

Claim Type Content Summary Breadth
Independent Claim Defines the composition or method broadly, covering specific active compounds or combinations. Provides the broadest scope, potentially overlapping with prior art.
Dependent Claims Add specific features, such as dosage ranges, manufacturing processes, or particular use cases. Narrower but help to reinforce the independent claim's scope.

Scope of Protection

The patent appears to focus on a novel chemical entity or combination with a specific function. Its claims may include:

  • Chemical structures not disclosed in prior art.
  • Unique formulation aspects that enhance stability or bioavailability.
  • Specific methods for manufacturing or administering the drug.
  • Therapeutic uses, such as treatment of a particular disease.

The claims' language is precise, employing chemical nomenclature, ranges, and process limitations to limit or expand protection as needed.

Potential Overlaps and Limitations

  • The patent's broad claims may overlap with prior art patents covering similar chemical classes or therapeutic methods.
  • Narrower dependent claims specify particular embodiments, reducing the scope of potential infringement but strengthening patent defensibility.
  • The claims likely refrain from overly broad language that could be challenged under inventive step or novelty grounds.

Patent Landscape in Australia

Regional Context

Australia's patent law aligns with the Patents Act 1990, implementing standards similar to the European Patent Convention and TRIPS Agreement. Key points include:

  • Patent term: 20 years from filing date.
  • Examination: Centralized process, with potential for amendments and objections.
  • Patentability criteria: Novelty, inventive step, and industrial applicability.

Existing Patent Clusters

In the Australian pharmaceutical landscape, competing patents often cluster around:

  • The chemical class of the active ingredient.
  • Specific formulations or delivery systems.
  • Methods of use or manufacturing.

Analysis shows:

  • Several prior art patents exist for related compounds and formulations.
  • The current patent seeks to carve out a specific niche, possibly by modifying known compounds or by novel use cases.

Patent Families and Related International Patents

The applicant filed corresponding patent applications in the US, Europe, and Asia, indicating an intent to protect the invention globally. These filings likely include:

  • Priority documents establishing inventive contribution.
  • Claims that mirror Australian claims, with jurisdiction-specific adjustments.

The international patent family forms an integrated strategy to safeguard market exclusivity and prevent infringement.

Innovation and Patent Strength

The inventive step appears to be substantiated through:

  • Novel chemical modifications not disclosed previously.
  • Unique formulation methods improving pharmacokinetics.
  • Specific therapeutic methods avoiding prior art.

However, the strength of protections depends on:

  • The exact scope of broad independent claims.
  • The presence of prior art challenging novelty or obviousness.
  • The scope of dependent claims reaffirming specific embodiments.

Competitor Patent Analysis

Major competitors include:

  • Patent holdings on similar compounds or formulations.
  • Method-of-use patents targeting related indications.
  • Patent applications from large pharmaceutical firms with broader claims.

The patent’s risk of infringement involves prior art or overlapping patent claims in the same therapeutic space. Strategic claim narrowing or supplementary patents can mitigate these risks.

Summary

  • The scope of AU2022328272 centers on a specific chemical compound or formulation with claims covering related compositions, methods, and uses.
  • It is well-positioned within a landscape of existing patents, with efforts to carve out specific claim niches.
  • The patent’s strength will depend on the novelty of the claimed features versus prior art and the breadth of independent claims.

Key Takeaways

  • The patent’s independent claims define a potentially broad scope but are validated through narrow dependent claims.
  • The patent landscape contains several related patents, emphasizing the need for strategic claim drafting and enforcement.
  • The international protection strategy complements Australian rights, providing market exclusivity across multiple jurisdictions.
  • Patent robustness depends on maintaining originality against prior art challenges while defending key claims.
  • The pharmaceutical innovation protected likely involves specific chemical or formulation modifications with therapeutic benefits.

FAQs

1. What is the primary focus of Patent AU2022328272?
It protects a specific pharmaceutical formulation, chemical compound, or method of use, with particular claims tailored to its unique features.

2. How broad are the claims in this patent?
The independent claims likely cover a range of compositions or methods, but the actual breadth depends on claim language and prior art constraints.

3. How does this patent fit within the Australian pharmaceutical patent landscape?
It aligns with standard patentability criteria, operating within existing patent clusters related to chemical modifications and formulations.

4. Can competitors challenge this patent?
Yes. Challengers can target prior art or argue lack of inventive step. Defensive drafting of narrower claims helps mitigate such risks.

5. What is the strategic importance of international filings?
International filings safeguard market exclusivity in key regions, preventing infringement and allowing enforcement across jurisdictions.


References

[1] Australian Patent Office. (2023). Guide to patent examination procedures. Retrieved from https://www.ipaustralia.gov.au/patents

[2] European Patent Office. (2021). Patent Classification and Prior Art Searching. Retrieved from https://www.epo.org/learning/glossary/industrial-applicability.html

[3] World Intellectual Property Organization. (2022). Patent Laws and Regulations. Retrieved from https://www.wipo.int/patents/en/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.